Delivery Order SPE2DB22D9316-SPE2DB24FYN31
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $8,509.92 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4564403579 - PERJETA 420 MG/14 ML VIAL 14ML, with a completion date of May 15, 2024. DMS Pharmaceutical Group is an experienced pharmaceutical wholesaler that provides a wide range of branded and generic drugs, biologics, and medical supplies to support the recurring...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $25,529.76 contract is for the delivery of PERJETA 420 MG/14 ML VIAL 14ML pharmaceuticals with a completion date of February 5, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug supplies to the federal government, primarily the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $34,039.68 and has an ultimate completion date of July 19, 2024. The contract is for the delivery of the pharmaceutical product PERJETA 420 MG/14 ML VIAL 14ML, with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,114.54 contract is for the delivery of PERJETA 420 MG/14 ML VIAL 14ML, with a period of performance through July 28, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a quantity of the pharmaceutical product PERJETA 420 MG/14 ML VIAL 14ML. The potential value of this delivery order is $51,059.52, with a completion date of February 12, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds numerous federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals...
- The Defense Logistics Agency awarded a firm fixed-price delivery order contract worth $42,549.60 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of PERJETA 420 MG/14 ML VIAL 14ML pharmaceutical products, with a completion date of February 15, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with DLA, valued up to $4,999,999, that enables the agency to issue delivery orders for a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of a pharmaceutical product, PERJETA 420 MG/14 ML VIAL 14ML, with a ceiling value of $4,557.26 and an ultimate completion date of July 28, 2025. The contract is not set aside for any specific program or type of business. DMS Pharmaceutical Group Inc. is a key supplier of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The $25,529.76 contract is for the supply of 4564110226 PERJETA 420 MG/14 ML VIAL 14ML, with a performance period through April 16, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDV) with the DLA, valued up to $4,999,999 through 2025, which enables the agency to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $27,343.62 contract is for the delivery of PERJETA 420 MG/14 ML VIAL 14ML and does not have a set-aside designation. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
- The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4563188467 - PERJETA 420 MG/14 ML VIAL 14ML. The delivery order has a potential value of $41,385.00 and is scheduled for completion by January 18, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to support...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB24FYN31Delivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business organization. The contract is for the delivery of PERJETA 420 MG/14 ML VIAL 14ML, a pharmaceutical product, with a potential value of $8,509.92 and a completion date of February 23, 2024. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a range of brand and generic pharmaceutical products to U.S. government agencies, including the Department of Veterans Affairs and the Department of Defense, through various prime and sub-federal contract vehicles. This delivery order contract is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, valued at up to $4,999,999 through the end of 2025, which enables the agency to order a broad range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 2/1/24 |